Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.44B |
| 2 |
Microsoft
MSFT
|
+$556M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$433M |
| 4 |
Johnson & Johnson
JNJ
|
+$349M |
| 5 |
Amazon
AMZN
|
+$340M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$873M |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$799M |
| 3 |
Colgate-Palmolive
CL
|
+$602M |
| 4 |
Palo Alto Networks
PANW
|
+$574M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$405M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Financials | 13.96% |
| 3 | Healthcare | 12.45% |
| 4 | Miscellaneous | 11.59% |
| 5 | Consumer Discretionary | 10.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Grocery Outlet
GO
$1.1B
| $3.49M | ﹤0.01% |
104,820
-32,430
| -24% | -$1.32M |
|
1352
Wendy's
WEN
$1.25B
| $3.49M | ﹤0.01% |
186,754
+59,418
| +47% | +$1.2M |
|
1353
iShares MSCI South Korea ETF
EWY
$27.4B
| $3.48M | ﹤0.01% |
73,458
+14,396
| +24% | +$821K |
|
|
TRIS
1354
DELISTED
Tristar Acquisition I Corp.
TRIS
| $3.47M | ﹤0.01% |
350,000
| – | – |
|
|
JOYY
1355
JOYY Inc
JOYY
$3.91B
| $3.46M | ﹤0.01% |
132,971
-6,792
| -5% | -$186K |
|
1356
CALL
Uber
UBER
$142B
| $3.45M | ﹤0.01% |
+130,200
| New | +$3.6M |
|
|
AVAN
1357
DELISTED
Avanti Acquisition Corp.
AVAN
| $3.44M | ﹤0.01% |
343,294
| – | – |
|
1358
nVent Electric
NVT
$26.6B
| $3.44M | ﹤0.01% |
108,699
-2,093
| -2% | -$69.9K |
|
1359
Allogene Therapeutics
ALLO
$570M
| $3.43M | ﹤0.01% |
317,766
+287,087
| +936% | +$3.9M |
|
|
WAVC
1360
DELISTED
Waverley Capital Acquisition Corp. 1
WAVC
| $3.42M | ﹤0.01% |
350,000
| – | – |
|
|
DEN
1361
DELISTED
Denbury Inc.
DEN
| $3.42M | ﹤0.01% |
39,626
+3,892
| +11% | +$298K |
|
1362
ITT
ITT
$18.4B
| $3.4M | ﹤0.01% |
52,128
+19,749
| +61% | +$1.44M |
|
1363
Tetra Tech
TTEK
$8.68B
| $3.39M | ﹤0.01% |
131,915
+46,980
| +55% | +$1.31M |
|
|
BORR
1364
Borr Drilling
BORR
$1.3B
| $3.38M | ﹤0.01% |
1,017,983
-614,623
| -38% | -$2.28M |
|
1365
Travere Therapeutics
TVTX
$5.6B
| $3.37M | ﹤0.01% |
136,913
+111,357
| +436% | +$2.88M |
|
1366
Jefferies Financial Group
JEF
$11B
| $3.37M | ﹤0.01% |
119,602
-20,730
| -15% | -$627K |
|
|
CIVI
1367
DELISTED
Civitas Resources
CIVI
| $3.37M | ﹤0.01% |
58,649
+10,693
| +22% | +$630K |
|
|
EPHY
1368
DELISTED
Epiphany Technology Acquisition Corp. Class A Common Stock
EPHY
| $3.36M | ﹤0.01% |
340,510
+25,691
| +8% | +$254K |
|
1369
Relay Therapeutics
RLAY
$3.83B
| $3.36M | ﹤0.01% |
150,211
+80,404
| +115% | +$1.76M |
|
|
ASAQ
1370
DELISTED
Atlantic Avenue Acquisition Corp
ASAQ
| $3.36M | ﹤0.01% |
334,733
| – | – |
|
1371
Revolution Medicines
RVMD
$43.9B
| $3.35M | ﹤0.01% |
169,917
+139,256
| +454% | +$3.06M |
|
1372
Post Holdings
POST
$3.32B
| $3.34M | ﹤0.01% |
40,789
+1,438
| +4% | +$124K |
|
1373
Cameco
CCJ
$38.4B
| $3.33M | ﹤0.01% |
125,748
-35,337
| -22% | -$904K |
|
|
HCAR
1374
DELISTED
Healthcare Services Acquisition Corporation Class A Common Stock
HCAR
| $3.32M | ﹤0.01% |
334,398
+34,242
| +11% | +$339K |
|
1375
Riot Platforms
RIOT
$8.63B
| $3.31M | ﹤0.01% |
472,667
+151,181
| +47% | +$1.06M |
|
Similar funds
Barclays's Q3 2022 Portfolio in Review
As of Q3 2022, Barclays held 5,400 positions worth $91.6B, down 44% from $163B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Barclays deployed $5.45B of net new capital in Q3 2022, opening 261 new positions and adding to 1,854 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $27.1M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $873M trimmed.
- Barclays's largest Q3 2022 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $27.1M.
- Barclays added most to Apple in Q3 2022, an estimated $1.44B increase.
- Barclays's biggest Q3 2022 reduction was Invesco QQQ Trust, cutting an estimated $873M.
- Barclays fully exited Vonage Holdings Corporation in Q3 2022, selling an estimated $99.4M.
- Barclays's ten largest holdings make up 22% of its $91.6B portfolio in Q3 2022.
- Barclays opened 261 new positions and closed 533 in Q3 2022.
- Barclays's portfolio value fell 44% quarter-over-quarter to $91.6B.
Based on Barclays's 13F filing for Q3 2022, filed 3 Nov 2022.